Highlights
IPI broadens scientific expertise with new talent
In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who’ve joined IPI from around the world,…
From president and CEO Ken Fasman: IPI in the midst of an exciting growth year
I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering, neuroscience and genomics, and…
The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents
Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies and other reagents—and expertise about where and how to use them Boston, June 8, 2023…
IPI starts new chapter with game-changing gift: A Q&A with Tim Springer
Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a history of scientific renown and entrepreneurial success, Institute for Protein Innovation (IPI) cofounder Tim Springer,…
Harvard professor and entrepreneur Tim Springer donates $210 million to the Institute for Protein Innovation
The gift further positions the emerging nonprofit to transform biomedical research with novel protein tools and expertise BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI), a nonprofit…
Sophia Ulmer brings creativity and computational prowess to protein engineering
Art and science can seem at odds. But fundamentally, both focus on exploration and the discovery of the unknown. In the Institute for Protein Innovation (IPI) laboratory, Sophia Ulmer mixes…
Chasing a ‘quantum leap’ in cell surface biology: A Q&A with Junichi Takagi
Cell surface receptors are, by and large, the main molecular target for therapeutics. Also known as transmembrane receptors, they’re the targets of more than 60% of drugs today. But scientists…
Institute for Protein Innovation welcomes top researchers at first symposium
BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing, a symposium on cell surface receptor biology, on Thursday, June 15, 2023. The free, day-long…
Uncovering the secrets of mechanotransduction, one integrin receptor at a time
For the body to function, cells must decide. Embryonic cells elect to reproduce and shape into budding limbs. Immune cells choose to leave the bloodstream en route to an infection…
Engineering Protein A to Z for VH3 antibody purification
Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies for research and drug development and a standard part of antibody production at the Institute…
At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility
In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein tools would be affordable, proffered…
Uncovering the secrets of mechanotransduction, one integrin receptor at a time
For the body to function, cells must decide. Embryonic cells elect to reproduce and shape into budding limbs. Immune cells choose to leave the bloodstream en route to an infection…
New federation aims to transform biology with protein tools spanning proteome by 2035
An ambitious protein moonshot is gaining momentum to develop and widely share tools that will land us understanding of the complete human proteome. In 2003, biology was all about the…
From Rob Meijers, interim executive director: In 2021, IPI explored ‘new frontiers’ in antigen and antibody discovery
As the world struggled to live in and through a seeming “forever pandemic,” 2021 was a year that demanded global resilience. The potency of delta followed by fast spread of…
A mystery launched a decade-long quest, leading to a novel cause of bone marrow failure
Twelve years ago, after a routine check-up of a newborn, a medical resident inadvertently ordered a nonroutine blood test. The results came as a surprise: The infant had virtually no…
Ubiquitous yet less severe, did omicron sacrifice virulence to evade immunity?
According to conventional wisdom, a SARS-CoV-2 variant becomes more infectious when it mutates to better bind and invade host cells. But a new study on omicron, which carries quadruple the…
Super toxin linked to food poisoning could bind to all human cells, cause other illnesses
Grape-like clusters of the bacterium Staphylococcus aureus might look harmless under a microscope. But they’re capable of causing great mayhem. Think food poisoning, a result of S. aureus’ most common…
Antibodies are going from biology’s workhorses to precision tools, a boon for reliable research
Roughly a decade ago, biologists conducting high-stakes experiments noticed a pattern: Many findings couldn’t be replicated in other labs, throwing doubt on data that should have led to treatments for…
To try to hone COVID-19 vaccines beyond variants, scientists can zoom in on mutations
Concern that omicron, the latest coronavirus variant, could be poised to overtake delta, which swept the globe in roughly two months since it was first identified, has steadily grown. But…
The German translation for opioid
An opioid crisis in the US is not news. Indeed, the Centers for Disease Control and Prevention estimate nearly 841,000 people in the US have died in the last two…
For IPI Board member Auro Nair, biotech is an outlet for good
Growing up in Malaysia, Auro Nair learned two basic tenets from his parents: Be a good person and do well in school. These maxims may have seemed simplistic to a…
Dissecting the nervous system’s self-assembly toolkit: A Q&A with Alex Jaworski
Early in development, an embryo begins an epic undertaking: the building of its nervous system. As part of the process, neurons send out axons on extraordinary journeys to distant targets.…
Jazz and a journey to biotech: Issi Rozen brings creative spirit to IPI Board
Becoming a jazz guitarist starts with a soul-catching chord. That initial spark of inspiration is followed by hours of practice to learn scales and complex harmonies, decades of determination to…
IPI broadens scientific expertise with new talent
In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who’ve joined IPI from around the world,…
From president and CEO Ken Fasman: IPI in the midst of an exciting growth year
I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering, neuroscience and genomics, and…
IPI starts new chapter with game-changing gift: A Q&A with Tim Springer
Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a history of scientific renown and entrepreneurial success, Institute for Protein Innovation (IPI) cofounder Tim Springer,…
Sophia Ulmer brings creativity and computational prowess to protein engineering
Art and science can seem at odds. But fundamentally, both focus on exploration and the discovery of the unknown. In the Institute for Protein Innovation (IPI) laboratory, Sophia Ulmer mixes…
Chasing a ‘quantum leap’ in cell surface biology: A Q&A with Junichi Takagi
Cell surface receptors are, by and large, the main molecular target for therapeutics. Also known as transmembrane receptors, they’re the targets of more than 60% of drugs today. But scientists…
Bioscience leader Ken Fasman to steer IPI as new president and CEO
The walls of Ken Fasman’s ninth-floor office are still bare. But the new president and CEO at the Institute for Protein Innovation (IPI) has plans that could fill the room.…
Dream come true: Zehra Sayers builds structural biology for the next generations
Zehra Sayers always dreamed of finding precise answers to life’s core questions. A professor and former president of Turkey’s Sabancı University — and one of the BBC’s most influential women…
Engineering Protein A to Z for VH3 antibody purification
Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies for research and drug development and a standard part of antibody production at the Institute…
Inside the IPI pipeline
Of the tools underpinning biomedical research, antibodies are among the most impactful. Their ability to recognize and attach to biomolecules has powered fundamental discoveries, diagnostic methods and treatments for diseases,…
Integrins: Explained
More than 600 million years ago, out of the depths of the metazoa, a protein family emerged — one that would persist through evolution and come to shape life today.…
The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents
Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies and other reagents—and expertise about where and how to use them Boston, June 8, 2023…
Harvard professor and entrepreneur Tim Springer donates $210 million to the Institute for Protein Innovation
The gift further positions the emerging nonprofit to transform biomedical research with novel protein tools and expertise BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI), a nonprofit…
Institute for Protein Innovation welcomes top researchers at first symposium
BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing, a symposium on cell surface receptor biology, on Thursday, June 15, 2023. The free, day-long…
Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman, Ph.D. as president and chief executive officer
Boston, November 15, 2022 — The Institute for Protein Innovation (IPI), a nonprofit research organization advancing protein science to accelerate biomedical research and improve human health, today announced the appointment…
AI Proteins secures $18.2 million seed round to pioneer high-throughput platform for advanced miniprotein therapeutics
Company to focus on the rapid development of miniproteins tailor-made for therapeutics, driving down costs and shortening the time required to develop safer, more effective medicines. BOSTON—(BUSINESS WIRE)—AI Proteins, the…
IPI co-founder Timothy Springer wins Lasker Award, highlighting key chapter in biology
Scientist, entrepreneur and philanthropist Timothy Springer is one of three scientists to win the 2022 Albert Lasker Award for Basic Medical Research, widely regarded as America’s top biomedical research prize.…
IPI joins an exciting effort to solve the reproducibility crisis
IPI is thrilled to join YCharOS as a member of its new Industry Advisory Committee. The Canadian company, named from a truncation of Antibody Characterization through Open Science, is launching…
Christopher Bahl selected as a TED Fellow
Institute for Protein Innovation Head of Protein Design to present at TED2019, joining the newest class of 20 global visionaries. BOSTON, Jan. 23, 2019 /PRNewswire/ — Molecular Engineer Chris Bahl…
IPI appoints Wei Yang as director of target discovery and Sharon Klein as director of philanthropy
Boston, June 26, 2018 /PR Newswire/ – Institute for Protein Innovation (IPI), a non-profit research organization focused on empowering research in protein science and developing open-source monoclonal antibodies, announced today…
IPI relocates to Boston’s Longwood Medical and Academic Area
BOSTON, May 21, 2018 /PRNewswire/ — Just one year after launch, IPI has relocated to the Harvard Institutes of Medicine at 4 Blackfan Circle, Boston. The 12,000-square-foot lab space represents a dramatic expansion and…